PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 29 filers reported holding PDS BIOTECHNOLOGY CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $116,125 | -26.0% | 39,633 | -0.0% | 0.00% | – |
| Q1 2024 | $156,978 | -25.1% | 39,641 | -6.0% | 0.00% | – |
| Q4 2023 | $209,555 | -6.0% | 42,164 | -4.5% | 0.00% | – |
| Q3 2023 | $222,917 | -18.6% | 44,142 | -18.9% | 0.00% | – |
| Q2 2023 | $273,798 | -18.6% | 54,433 | -0.5% | 0.00% | – |
| Q1 2023 | $336,528 | +43718.8% | 54,720 | -6.1% | 0.00% | – |
| Q4 2022 | $768 | -99.1% | 58,270 | +91.8% | 0.00% | – |
| Q3 2022 | $90,000 | -21.1% | 30,381 | -2.5% | 0.00% | – |
| Q2 2022 | $114,000 | -73.5% | 31,170 | -55.2% | 0.00% | – |
| Q1 2022 | $431,000 | +52.8% | 69,628 | +99.9% | 0.00% | – |
| Q4 2021 | $282,000 | +3033.3% | 34,831 | +168.1% | 0.00% | – |
| Q1 2020 | $9,000 | -76.3% | 12,991 | -10.5% | 0.00% | – |
| Q4 2019 | $38,000 | -20.8% | 14,516 | 0.0% | 0.00% | – |
| Q3 2019 | $48,000 | -44.8% | 14,516 | 0.0% | 0.00% | – |
| Q2 2019 | $87,000 | – | 14,516 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INSPIRION WEALTH ADVISORS, LLC | 314,684 | $1,935,307 | 0.39% |
| Iron Gate Global Advisors LLC | 75,016 | $461,348 | 0.11% |
| Sofinnova Investments, Inc. | 142,635 | $877,205 | 0.06% |
| EP Wealth Advisors, LLC | 38,337 | $2,912,486 | 0.05% |
| Total Clarity Wealth Management, Inc. | 14,362 | $88,326 | 0.05% |
| Andesa Financial Management Inc. | 25,000 | $76,875 | 0.04% |
| Jump Financial, LLC | 68,471 | $421,097 | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 589,050 | $3,622,658 | 0.01% |
| TWO SIGMA ADVISERS, LP | 584,400 | $3,594,060 | 0.01% |
| HRT FINANCIAL LP | 88,385 | $543 | 0.01% |